Format

Send to

Choose Destination
Semin Cancer Biol. 2018 Oct;52(Pt 2):v-vi. doi: 10.1016/j.semcancer.2018.08.004. Epub 2018 Aug 4.

In the beginning, there was chaos: A perspective on the development of immuno-oncological biomarkers.

Author information

1
Department of Pathology, GZA-ZNA, Antwerp, Belgium, Division of Research and Cancer Medicine, Peter Mac Callum Cancer Centre, University of Melbourne, Victoria, Australia. Electronic address: roberto@salgado.be.
2
Cancer Diagnosis Program, National Cancer Institute, Rockville, Maryland, United States.
3
Laboratory for Experimental and Translational Research on Radiation Oncology (EXTRO-Lab), Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Tyrolean Cancer Research Institute, Innsbruck, Austria.
4
Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
5
Division of Research and Cancer Medicine, Peter Mac Callum Cancer Centre, University of Melbourne, Victoria, Australia.
PMID:
30086389
DOI:
10.1016/j.semcancer.2018.08.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center